Navar

EverythingALS Launches the Vision 2030 AI Hub: Charting the Path to an ALS Cure and Advancing Neurodegenerative Disease Research

Retrieved on: 
Tuesday, March 12, 2024
Research, Neurology, Harvard Medical School, Synthetic media, Machine learning, Government, Regeneration, Prevalence, Massachusetts General Hospital, Science, Environment, MIT, Data science, SAN, Knowledge, Biomarker, History, Hope, Doctor of Philosophy, LLM, Vision 2030, Hub, Ecosystem, Drug development, Navar, Frontotemporal dementia, Artificial intelligence, Generative, Mass, Medicine, Medical device

The Vision 2030 AI Hub will have a laser focus on "repair and regeneration," aiming to distinguish the organization in the ALS research landscape.

Key Points: 
  • The Vision 2030 AI Hub will have a laser focus on "repair and regeneration," aiming to distinguish the organization in the ALS research landscape.
  • The Vision 2030 AI Hub epitomizes this momentous convergence—where the cumulative advances in ALS research and technology coalesce, heralding a new epoch of hope and discovery.
  • The Vision 2030 AI Hub motivates giving and fundraising, showcasing an innovative operating model that emphasizes urgency in tackling ALS and other disorders.
  • For more information about EverythingALS, Vision 2030, and the AI Hub visit http://www.v2030.org or email us at [email protected] .

Union Square Advisors Hires Top HealthTech Dealmakers Ezequiel Navar and Alexander Despo to Expand Practice and Offerings

Retrieved on: 
Wednesday, September 13, 2023
Zeke, RCM, Association of British HealthTech Industries, Entrepreneurship, AI, Jefferies, Smith, Houlihan Lokey, Vetter Pharma, Dimitris Despos, Patient, Navar, SAN, Pharmaceutical industry

NEW YORK and SAN FRANCISCO, Sept. 13, 2023 /PRNewswire/ -- Union Square Advisors, a leading technology-focused investment bank, today announced the expansion of its HealthTech practice through the hires of Managing Director Ezequiel (Zeke) Navar and Vice President Alexander (Alex) Despo. Effective immediately, Navar will lead the firm's practice and report directly to Co-Founder, Partner and President Ted Smith.

Key Points: 
  • NEW YORK and SAN FRANCISCO, Sept. 13, 2023 /PRNewswire/ -- Union Square Advisors , a leading technology-focused investment bank, today announced the expansion of its HealthTech practice through the hires of Managing Director Ezequiel (Zeke) Navar and Vice President Alexander (Alex) Despo.
  • Effective immediately, Navar will lead the firm's practice and report directly to Co-Founder, Partner and President Ted Smith.
  • Navar and Despo will take a focused and thematic approach to HealthTech coverage, combining their broad transaction experience with deep insights into the intersection of both industries.
  • "It is an honor to become a part of the Union Square Advisors team and lead this important practice," said Navar.